An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and assertions of rapid British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is worrisome and could result in users administering products of unknown origin.
Some experts stated the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or imprisonment.
Service Reaction and Material Removal
According to TikTok, the service has taken down problematic content and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Research also found groups with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, populated with images of weight loss, positive testimonials and detailed guides for preparing or injecting at residence.
After moments of entering one community, a vendor shared contact information, where most transactions take place. The seller sent an instruction manual and promised delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.
Product Details and Pricing
Within these communities, messages display dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When questioned how long a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Measures
A representative for the messaging service said it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to possibly serious medical dangers”.
